Klinische Studien Hepatologie

Hier finden Sie Informationen zu den aktuellen klinischen Studien in diesem Bereich.

Sie befinden sich hier:

Ansprechpartner

Doreen Baier

Studienschwester Leberambulanz

Konterfei_neutral_155x200.png
Angelika Göbels

Studienschwester Leberambulanz

Konterfei_neutral_155x200.png
PD Dr. med. Tobias Müller

Leitender Oberarzt Campus Virchow-Klinikum (CVK)

PD Dr. med. Tobias Müller, Hepatologie und Gastroenterologie, Leitender Oberarzt, Campus Virchow-Klinikum (CVK)

Aktuelle klinische Studien Hepatologie

Nicht-interventionelle Studie Deutsches Hepatitis C-Register (HCV Register)
Ansprechpartner: PD Dr. T. Müller, A.-C. Wilde

STELLARIS_Rollover 3
Ansprechpartner: Ansprechpartner: PD Dr. T. Müller, A.-C. Wilde

A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Cenicriviroc for the Treatment of Li ver Fibrosis in Adult Subjects with Nonalcoholic Steatohepatitis
Ansprechpartner: PD Dr. T. Müller, A.-C. Wilde

A two-part randomized, double-blind, placebo-controlled multicenter <lose ranging and confirmatory study to assess the safety and efficacy of VA Y736 in autoimmune hepatitis patients with incomplete response to or intolerance of standard therapy (AMBER)
Ansprechpartner: PD Dr. T. Müller, A.-C. Wilde

A randomized, double-blind, placebo controlled, 2- part, adaptive design, multicenter 12-week study to assess safety, tolerability and efficacy of LJN452 in patients with non-alcoholic steatohepatitis (NASH) (CLJN452A2202)
Ansprechpartner: PD Dr. T. Müller, A.-C. Wilde

Prevention of Mortality with Long-­Term Administration of Human Albumin in Subjects with Decompensated Cirrhosis and Ascites
Ansprechpartner: PD Dr. T. Müller, A.-C. Wilde

A Phase 3, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Obeticholic Acid in Subjects with Compensated Cirrhosis due to Nonalcoholic Steatohepatitis
Ansprechpartner: PD Dr. T. Müller, A.-C. Wilde